Ozempic and similar GLP-1 weight-loss medications are designed to be a lifelong treatment. But a new study finds the majority ...
The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...
Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...
Novo Nordisk said Wednesday it will sell Wegovy for $499 a month ... the FDA said the shortage was over and told compounders to stop making copies of weight-loss drugs by May.
Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.
The move comes just over a week after rival Eli Lilly cut the price for vials of its weight-loss ... copies of Wegovy while the medicines were in shortage are also running out of time to ...